News
Article
Author(s):
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.